Status:
COMPLETED
Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events
Lead Sponsor:
Universidade Gama Filho
Collaborating Sponsors:
Instituto Nacional de Cardiologia de Laranjeiras
Conditions:
Systemic Arterial Hypertension
Hypertension Resistant to Conventional Therapy
Eligibility:
All Genders
18-80 years
Brief Summary
Renin-angiotensin-aldosterone system (RAAS) polymorphisms influence 24h arterial pressure fluctuation. Resistant systemic arterial hypertension (RSAH) has an increased risk of end organ damage and unf...
Eligibility Criteria
Inclusion
- Subjects with uncontrolled systemic arterial hypertension despite use of three anti-hypertensive drugs, including one diuretic
Exclusion
- Secondary causes of systemic arterial hypertension
Key Trial Info
Start Date :
June 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT01173029
Start Date
June 1 2001
End Date
December 1 2010
Last Update
April 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Nacional de Cardiologia
Rio de Janeiro, RH, Brazil, 22240-006